argenx SE
General ticker "ARGNF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $45.1B (TTM average)
argenx SE follows the US Stock Market performance with the rate: 38.5%.
Estimated limits based on current volatility of 4.2%: low 732.82$, high 797.37$
Factors to consider:
- Earnings expected soon, date: nan
Short-term ARGNF quotes
Long-term ARGNF plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $2,190.23MM | $4,320.27MM |
| Operating Expenses | $2,211.89MM | $3,311.35MM |
| Operating Income | $-21.65MM | $1,008.92MM |
| Non-Operating Income | $106.83MM | $321.73MM |
| Interest Expense | $2.46MM | $4.25MM |
| R&D Expense | $949.30MM | $1,419.65MM |
| Income(Loss) | $85.18MM | $1,330.65MM |
| Taxes | $-747.86MM | $-13.97MM |
| Profit(Loss)* | $1,687.73MM | $1,344.62MM |
| Stockholders Equity | $5,498.28MM | $7,323.47MM |
| Inventory | $407.23MM | $473.55MM |
| Assets | $6,202.52MM | $8,683.14MM |
| Operating Cash Flow | $-82.75MM | $882.37MM |
| Capital expenditure | $1.80MM | $6.42MM |
| Investing Cash Flow | $-717.59MM | $854.76MM |
| Financing Cash Flow | $279.76MM | $242.49MM |
| Earnings Per Share** | $28.20 | $21.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.